Welcome to our dedicated page for SS Innovations International news (Ticker: $SSII), a resource for investors and traders seeking the latest updates and insights on SS Innovations International stock.
SS Innovations International, Inc (SSII) was founded by a seasoned leadership team with vast experience in medical research, innovation, and development in the medical robotics sector. The company aims to meet the rising demand for practical medical robotic devices by creating a platform-independent precision guidance system, initially focusing on skin resurfacing.
The flagship SSi Mantra surgical device has been utilized in over 1000 procedures, showcasing the company's commitment to advancing robotic surgery. Dr. Sudhir Srivastava, the Chairman and CEO of SS Innovations, highlights the Mantra's fifth arm capability, enabling complex cardiac surgeries with minimal invasiveness, reduced blood loss, quicker recovery times, and superior outcomes.
The global market for cardiac surgery devices and surgical robotics is growing rapidly, presenting significant opportunities for SS Innovations. The Company's innovative approach and unique value proposition position it well for future success and market expansion.
Rhea-AI Summary
SS Innovations International, Inc. (SSII) has partnered with Medikabazaar, a leading medical equipment supplier in India, to facilitate sales of its flagship SSi Mantra Surgical Robotic System to hospitals and medical facilities across India. The partnership aims to make robotic surgery affordable and accessible to a global population, with the SSi Mantra Surgical Robotic System being the first surgical system made in India, granted regulatory approval in India and Guatemala, and clinically validated in more than 40 different types of surgical procedures. The system is cost-effective with broad-spectrum surgical applications, including cardiac surgery, and has already been used in over 650 surgical procedures. SS Innovations is also seeking regulatory approvals in the United States and Europe, expected to be received in 2024 and 2025.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.51%
Tags
-
Rhea-AI Summary
SS Innovations International, Inc. hosted the inaugural SS Innovations Multi-Specialty Robotic Surgical Conference (SMRSC) in India, showcasing the SSi Mantra Surgical Robotic System. The event featured 13 live surgeries, panel discussions, and scientific sessions, with a focus on the integration of Artificial Intelligence in surgery and the pursuit of sustainable tele-surgery. The SSi Mantra is the first surgical robotic system made in India, with regulatory approval and clinical validation in over 40 different surgical procedures. The company is seeking regulatory approvals in the United States and Europe in 2024 and 2025.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.33%
Tags
-
Rhea-AI Summary
SS Innovations International, Inc. (OTC: SSII) has achieved significant milestones in 2023, including completing over 550 surgeries with the SSi Mantra surgical robotic system, receiving regulatory approvals in multiple countries, and entering into strategic partnerships and distribution agreements. The company is working towards securing regulatory approvals in the United States and Europe, with a focus on making robotic surgery accessible and affordable globally.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.9%
Tags
Rhea-AI Summary
SS Innovations International, Inc. (SSII) has entered a strategic partnership with Surgical Lab, Ltd., a Cairo-based medical device distributor, to provide accessibility to the SSi Mantra Surgical Robotic System for the entire African continent. Surgical Lab has begun registration of SSi Mantra in 27 African countries, marking a significant milestone for SS Innovations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.45%
Tags
-
Rhea-AI Summary
SS Innovations International, Inc. (SSII) completes 500 surgeries using SSi Mantra Surgical Robotic System, marking a significant milestone. The company's innovative surgical robotic technologies are making robotic surgery affordable and accessible globally. Dr. Sudhir P. Srivastava and Dr. Sudhir K. Rawal performed complex surgeries, with Dr. Rawal's team achieving the 500th procedure, making Rajiv Gandhi Cancer Institute the first healthcare institution in the Indian Subcontinent to acquire the system and perform the highest volume of clinical procedures in India. The SSi Mantra is the first affordable system with the potential to become the most used robotic surgical system in India over the next several years. Dr. Srivastava performed the 501st surgery, a first-of-its-kind procedure, launching the robotic cardiac surgery program at Narayana Hrudalayala Institute of Cardiac Sciences. The SSi Mantra Surgical Robotic System is cost-effective and clinically validated in more than 40 different types of surgical procedures, with regulatory approvals in India, the United Arab Emirates, and Guatemala, and expectations to secure approvals in the United States and Europe in the 2024 – 2025 time frame.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
SS Innovations International, Inc. appoints Dr. Sonia Shokeen as Head of Quality and Regulatory Affairs. Dr. Shokeen brings over 15 years of medical device experience and will lead SS Innovations' Product Lifecycle Management and regulatory strategy. SS Innovations also announced regulatory approval in Guatemala and a co-development partnership with Johns Hopkins University.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.01%
Tags
News
Rhea-AI Summary
SS Innovations International, Inc. receives Equity Report coverage from Argus Research
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.83%
Tags
-
Rhea-AI Summary
SS Innovations installs its SSi Mantra surgical robotic system at Johns Hopkins University's Baltimore campus.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
SS Innovations receives approval for clinical use of Mantra Surgical Robotic System in Guatemala
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.64%
Tags
Rhea-AI Summary
SS Innovations appoints Colin Eke as Senior Vice President of Global Business Development
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
FAQ
What is SS Innovations International, Inc's core focus?
SS Innovations specializes in developing medical robotic devices with a focus on platform-independent precision guidance systems.
How many procedures have used SS Innovations' flagship device?
The SSi Mantra surgical device has been utilized in over 1000 procedures, showcasing its effectiveness and impact in robotic surgery.
What differentiates the SSi Mantra surgical device in the market?
The Mantra's innovative design features a fifth arm capability, enabling it to perform complex cardiac surgeries with minimal invasiveness, reduced blood loss, and better patient outcomes.
What market trends support SS Innovations' growth?
The global market for cardiac surgery devices and surgical robotics is growing rapidly, presenting significant opportunities for SS Innovations' innovative solutions.
Who is Dr. Sudhir Srivastava and what is his role at SS Innovations?
Dr. Sudhir Srivastava is the Chairman and CEO of SS Innovations, leading the company's strategic market expansion and transformation of robotic surgery practices.
What is the projected growth rate of the global surgical robotics market?
The global surgical robotics market is projected to reach $188.8 billion by 2032, growing at a CAGR of 9.1% from 2023 to 2032, indicating a significant growth opportunity for SS Innovations.
How does SS Innovations plan to enhance its market position?
SS Innovations aims to receive FDA approval in the US and CE Mark approval in Europe in early 2025, further solidifying its market position and accelerating its global adoption.
What recent milestone did SS Innovations achieve with the SSi Mantra device?
SS Innovations reached a milestone with the SSi Mantra device, highlighting the company's strategic market expansion, access enhancement, and transformation of robotic surgery practices.
What is SS Innovations' competitive advantage in the medical robotics field?
SS Innovations' competitive advantage lies in its advanced platform-independent precision guidance system and innovative approach to robotic surgery, offering precise execution, less trauma, and superior overall outcomes.
How does SS Innovations plan to uplist its common stock to a National Securities Exchange?
SS Innovations has selected BDO to facilitate the uplisting of its common stock to a National Securities Exchange, demonstrating the company's commitment to transparent financial practices and regulatory compliance.
SS Innovations International, Inc.
OTC:SSII
SSII Rankings
SSII Stock Data
751.25M
32.82M
80.45%
Small Arms, Ordnance, and Ordnance Accessories Manufacturing
Manufacturing
United States of America
Orlando